Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, ...
Cannabidiol (CBD), a non-intoxicating compound in marijuana, “holds substantial promise as an anti-tumor agent” in addition to its other anti-inflammatory properties, a new scientific review ...
Electronic data capture (EDC) extract from the ongoing ACR-368 registrational-intent Phase 2b monotherapy trial in OncoSignature-positive (BM+) subjects with endometrial cancer (EC) showed 39% overall ...
The Lung Cancer Research Foundation® (LCRF) recently awarded five new research grants in the following areas: three LCRF ...
Two Complete Metabolic Responses (CMRs) observed in patients with relapsed/refractory metastatic Ewing sarcoma and one Complete Response (CR) ...
“We are encouraged by the emerging data from our lung cancer programs, where systemically delivered Olvi-Vec continues to ...
The US FDA has approved mosunetuzumab-axgb (Lunsumio VELO) as a subcutaneous (SC) formulation for the treatment of adult ...
A next-generation drug tested in yeast was found to extend lifespan and slow aging by influencing a major growth-control pathway. Researchers also uncovered an unexpected role for agmatinases, enzymes ...
Identifying the mechanisms of action driving a drug’s anti-cancer efficacy is critical for identifying optimal biomarkers, indications, and combinations for clinical success. Yet, systematically ...
Roughly a quarter of all cancerous tumors are caused by mutations in the KRAS gene, which fosters cell growth. For more than three decades, scientists believed these mutations were impervious to ...
Weekend mornings anchor, CBS New York; Correspondent, CBS News and Stations Elaine Quijano is a weekend mornings anchor for CBS New York and a correspondent for CBS News and Stations, contributing to ...
Scientists have discovered that boosting lysosome activity helps cells clear progerin, the toxic protein behind premature aging in progeria, offering a potential new way to fight aging-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback